UAB Wellgem Biopharma Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 298,561 |
| 44,964 |
| -309,729 |
| -309,729 |
| -46,646 |
| 93.13 |
| -103.74 |
| -332,427 |
| 1,999,702 |
| 1,480,036 |
| 185,537 |
| 2024 |
|---|
| 137,620 |
| 14,456 |
| -419,214 |
| -419,214 |
| -44,035 |
| -6.75 |
| -304.62 |
| -751,641 |
| 7,251,641 |
| 4,223,088 |
| 2,375,290 |
| 2025 |
|---|
| 243,300 |
| 11,909 |
| -1,041,912 |
| -1,041,912 |
| -50,999 |
| 73.19 |
| -428.24 |
| 1,206,448 |
| 8,498,131 |
| 9,413,965 |
| 251,577 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 243,300 |
| 11,909 |
| -1,041,912 |
| -1,041,912 |
| -50,999 |
| 73.19 |
| -428.24 |
| 1,206,448 |
| 8,498,131 |
| 9,413,965 |
| 251,577 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
243,300 €77 % *
Sales per employee (€)
11,909 €-18 % *
Profit before tax (€)
-1,041,912 €-149 % *
Net Profit (€)
-1,041,912 €-149 % *
Profit per employee (€)
-50,999 €-16 % *
Total profitability (%)
73.19 %1,184.30 % *
Net profitability (%)
-428.24 %-40.58 % *
Equity (€)
1,206,448 €261 % *
Amounts Payable And Liabilities (€)
8,498,131 €17 % *
Non-current Assets (€)
9,413,965 €123 % *
CurrentAssets (€)
251,577 €-89 % *
